Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration

British Journal of Ophthalmology

Volumn 88, Issue 1, 2004, Pages 114-119

  Marcus, D M ^a   Sheils, W C ^a   Young, J O ^a   McIntosh, S B ^a   Johnson, M H ^a   Alexander, J ^b   Samy, C N ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Ocala Eye Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IRRADIATION; KAPLAN MEIER METHOD; MALE; PHOTOTOXICITY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECURRENT DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; CONTRAST SENSITIVITY; DISEASE PROGRESSION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RECURRENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0345863697     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.88.1.114     Document Type: Article

References (31)

1. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization: five-year results from randomized clinical trials. Arch Ophthalmol 1994;112:500-9.
2. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy after five years: results from randomized clinical trials. Arch Ophthalmol 1991;109:1109-14.
3. Macular Photocoagulation Study Group. The influence of treatment extent on the visual acuity of eyes treated with krypton laser for juxtafoveal choroidal neovascularization. Arch Ophthalmol 1995;113:190-4.
4. Sorenson JA, Yannuzzi LA, Shakin JL. Recurrent subretinal neovascularization. Ophthalmology 1985;92:1059-73.
5. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 1986;104:503-12.
6. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1991;109:1232-41.
7. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macufar degeneration. Arch Ophthalmol 1994;112:489-99.
8. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials: TAP report 1. Arch Ophthalmol 1999;117:1329-45.
9. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: verteporfin in photodynamic therapy Report 2. Am J Ophthalmol 2001;131:541-60.
10. Submacular Surgery Trials Pilot Study Investigators Submacular surgery trials randomized pilot trial for laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic Outcomes: Submaculor Surgery Trials Pilot Study Report Number 1, Am J Ophthalmol 2000;130:387-407.
11. Spoide RF, Guyer DR, McCormick B, et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998;105:24-30.
12. Stolmans P, Leys A, Van Limbergen E. External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: A review of 111 cases. Retina 1997;17:481-92.
13. Postgens H, Bodanowitz S, Kroll P. Low-dose radiation therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1997;235:656-61.
14. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: A pilot study. Br J Ophthalmol 1993;77:265-73.
15. Freire J, Longton WA, Miyamoto CT, et al. External radiotherapy in macular degeneration: Technique and preliminary subjective response. Int J Radiation Oncology Biol Phys 1996;36:857-60.
16. Hart PM, et al. Teletherapy for subfoveal choroidal neovascularization of age-related macular degeneration: results of follow-up in a non-randomized study. Br J Ophthalmol 1996;80:1046-50.
17. Finger PT, Berson A, Sherr D, et al. Radiation therapy for subretinal neovascularization. Ophthalmology 1996;103:878-89.
18. Bergink GJ, Deutman AF, Van Den Broek JECM, et al. Radiation therapy for age-related subfoveal choroidal neovascular membranes. Doc Ophthalmol 1995;90:67-74.
19. Finger PT, Berson A, Ng T, et al. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999;127:170-7.
20. Yonemoto LT, Slater JD, Friedrichsen EJ. Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results. Int J Radiation Oncology Biol Phys 1996;36:867-71.
21. Flaxel CJ, Friedrichsen EJ, Smith JO, et al. Proton beam irradiation of subfoveal choroidal neovascularization in age-related macular degeneration. Eye 2000;14:155-64.
22. Bergink GJ, Hoyng CB, van der Maazen RWM, et al. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation. Graefes Arch Clin Exp Ophthalmol 1998;236:321-5.
23. Char DH, Irvine A, Posner MD, et al. Randomized trial of radiation for age-related macular degeneration. Am J Ophthalmol 1999;127:574-8.
24. Valmaggia C, Ries G, Ballinari P. Radiotherapy for sub-foveal choroidal neovascularization in age-related macular degeneration: A randomized clinical trial. Am J Ophthalmol 2002;133:521-9.
25. Ciulla TA, Danis RP, Klein SB, et al. Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial. Am J Ophthalmol 2002;134:905-6.
26. Kobayashi H, Kobayashi K. Age-related macular degeneration: Long-term results of radiotherapy for subfoveal neovascular membranes. Am J Ophthalmol 2000;130:617-35.
27. Hart PM, Chakravarthy U, Mackenzie G, et al. Visual outcomes in the subfoveal radiotherapy study. A randomized controlled trial of teletherapy for age-related macular degneration. Arch Ophthalmol 2002;120:1029-38.
28. The Radiation Therapy for Age-related Macular Degeneration (RAD) Study Group. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Ophthalmology 1999;106:2239-47.
29. Marcus DM, Sheils WC, Johnson MH, et al. External Beam Irradiation of Subfoveal Choroidal Neovascularization Complicating Age-Related Macular Degeneration: one-year results of a prospective, double-masked, randomized clinical trial. Arch Ophthalmol 2001;119:171-80.
30. Holz FG, Engenhart R, Bellmann C, et al. Stereotactic radiation therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Front Radiat Ther Oncol 1997;30:238-46.
31. D'Hollander F, Stalmans P, Van Limbergen E, et al. Retrospective study on the evolution of visual acuity after external beam radiotherapy (20 Gy, 2 Gy fractions) for subfoveal choroidal neovascular membranes in ARMD. Bull Soc Belge Ophthalmol 1998;270:27-34.